These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Progression of chronic renal insufficiency and its prevention using angiotensin converting enzyme inhibitors and angiotensin antagonists]. Tesar V Vnitr Lek; 2003 May; 49(5):365-9. PubMed ID: 12908169 [TBL] [Abstract][Full Text] [Related]
4. [In what way and how intensively should blood pressure be lowered in diabetic nephropathy?]. Krämer BK; Wieçek A; Ritz E Dtsch Med Wochenschr; 1997 Jun; 122(25-26):829-32. PubMed ID: 9244671 [No Abstract] [Full Text] [Related]
5. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors. Crook ED; Preddie DC Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155 [TBL] [Abstract][Full Text] [Related]
6. Best practice for hypertensive patients with kidney disease. de Zeeuw D Hosp Med; 2003 Feb; 64(2):96-100. PubMed ID: 12619337 [TBL] [Abstract][Full Text] [Related]
7. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?]. Luño J; Valderrábano F An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851 [No Abstract] [Full Text] [Related]
8. [Diabetic nephropathy. Are the blood pressure values set too low?]. Zidek W MMW Fortschr Med; 2003 Dec; 145(49):14. PubMed ID: 14963985 [No Abstract] [Full Text] [Related]
9. [Progressive renal failure. Why blood pressure must now be monitored]. Tepel M; van der Giet M; Zidek W MMW Fortschr Med; 2000 Jun; 142(25):42-4. PubMed ID: 10920669 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic options in diabetic renal disease and hypertension. Savage MW; Leese GP; Chattington P; Vora JP Br J Hosp Med; 1995 Nov 1-14; 54(9):429-34. PubMed ID: 8564177 [TBL] [Abstract][Full Text] [Related]
11. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
12. Clinical use of angiotensin-converting enzyme inhibitors in patients with renal impairment. Elliott HL Blood Press Suppl; 1994; 2():31-4. PubMed ID: 8061843 [TBL] [Abstract][Full Text] [Related]
13. Hypertension in end-stage renal disease: target values, methods of measurement and drug therapy. Zoccali C J Nephrol; 2002; 15(2):199-201. PubMed ID: 12018640 [No Abstract] [Full Text] [Related]
14. Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate-to-severe reductions in renal function. Saelen MG; Prøsch LK; Gudmundsdottir H; Dyrbekk D; Helge Hunderi O; Arnesen E; Paulsen D; Skjønsberg H; Os I Blood Press; 2005; 14(3):170-6. PubMed ID: 16036497 [TBL] [Abstract][Full Text] [Related]
15. [Control of arterial pressure in diabetic nephropathy]. Luño J; García de Vinuesa S Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304 [No Abstract] [Full Text] [Related]
17. Common Drugs for Stabilization of Renal Function in the Progression of Diabetic Nephropathy and Their Relations with Hypertension Therapy. Wang Y; Wang C; Zhang X; Gu HF; Wu L Curr Diabetes Rev; 2018; 14(2):149-161. PubMed ID: 28201968 [TBL] [Abstract][Full Text] [Related]
18. Losartan in patients with renal insufficiency. de Zeeuw D; Gansevoort RT; de Jong PE Can J Cardiol; 1995 Aug; 11 Suppl F():41F-44F. PubMed ID: 7664217 [TBL] [Abstract][Full Text] [Related]
19. Protecting the kidney in hypertension. Weinberg MS; Cottiero RA; Yoburn DC R I Med; 1993 May; 76(5):225-8. PubMed ID: 8518496 [No Abstract] [Full Text] [Related]
20. [The pathophysiology, treatment and prognosis of renal hypertension]. Abe K Nihon Jinzo Gakkai Shi; 2003; 45(1):1-11. PubMed ID: 12680314 [No Abstract] [Full Text] [Related] [Next] [New Search]